Document Detail


Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
MedLine Citation:
PMID:  8420229     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been postulated that a reduction in blood viscosity due to degradation of plasma fibrinogen may be of benefit to patients with acute myocardial infarction (AMI), who are treated with thrombolytic agents. The aims of this study were to investigate the time course of rheologic parameters, to identify the principal factors determining blood viscosity, and to find possible correlations between viscosity and cardiac function during thrombolytic therapy with anistreplase. Therefore, the viscosity of whole blood and plasma and the hematocrit were measured before and at 10 time points after thrombolysis in 10 patients with AMI. In addition, plasma fibrinogen and fibrin(ogen) degradation products were determined. Immediately after the start of thrombolysis, the viscosity of blood (both at high and low shear rate) and plasma decreased significantly and continued to do so for 24 hours. The mean hematocrit also decreased markedly, and even after correction for these hematocrit changes, the reduction in blood viscosity remained significant: it decreased to 72% of pretreatment (measured at low shear rate), whereas the high-shear viscosity decreased to 95% of baseline. The viscosity of plasma significantly decreased from 1.39 +/- 0.13 mPa.s (mean +/- SD) before thrombolysis to 1.22 +/- 0.08 mPa.s after 2 hours. There was a rapid, nearly complete depletion in fibrinogen, followed by a striking rebound after the second day. The decrease in blood viscosity lasted for 2 days after anistreplase and was mainly accounted for by the reduction in hematocrit. The contribution of fibrinogen to blood viscosity appeared less prominent. Despite these rheologic changes, no improvement in cardiac output was noticed in the patients.
Authors:
J J Hoffmann; J J Bonnier; P G Melman; I Bartholomeus
Related Documents :
3093959 - Blood rheology and myalgic encephalomyelitis: a pilot study.
18405459 - Premature red blood cells have decreased aggregation and enhanced aggregability.
6182069 - Integral viscosity: a useful parameter in evaluating whole blood and plasma viscosities...
19488109 - Three-dimensional volumetric measurement of red blood cell motion using digital hologra...
58309 - Abnormal blood viscosity in raynaud's phenomenon.
6540539 - Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peri...
7442589 - Fluctuations in blood cholesterol level: a rational analysis.
7092179 - Cerebral blood flow after experimental basal ganglia hemorrhage.
22738049 - Effects of syringe type and storage conditions on results of equine blood gas and acid-...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  71     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-02-05     Completed Date:  1993-02-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  14-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Clinical Laboratories (Hemostasis division), Catharina Hospital, Eindhoven, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anistreplase / therapeutic use*
Blood Coagulation Factors / analysis
Blood Viscosity*
Cardiac Output / physiology
Coronary Vessels / pathology
Female
Fibrin Fibrinogen Degradation Products / analysis
Fibrinogen / analysis
Hematocrit
Humans
Male
Middle Aged
Myocardial Infarction / blood*,  drug therapy*,  pathology,  physiopathology
Plasma
Regression Analysis
Rheology
Thrombolytic Therapy*
Vascular Patency
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors; 0/Fibrin Fibrinogen Degradation Products; 81669-57-0/Anistreplase; 9001-32-5/Fibrinogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Measurement of cardiac output by automated single-breath technique, and comparison with thermodiluti...
Next Document:  Effects of late (1 to 30 days) reperfusion after acute myocardial infarction on the signal-averaged ...